Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
- 6 April 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 80 (1), 27-35
- https://doi.org/10.1007/s11060-006-9135-z
Abstract
Summary Background Symptom occurrence has been shown to predict treatment course and survival in patients with solid tumors. Primary brain tumor (PBT) patients are unique in the occurrence of neurologic symptoms. Currently, no instrument exists that measures both neurologic and cancer-related symptoms. Methods Patients diagnosed with PBT participated in this study. Data was collected at one point in time and included demographic and clinical factors, and the M.D. Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT). The study evaluated the reliability and validity of the MDASI-BT in primary brain tumor patients. Results Two hundred and one patients participated in this study. Mean symptom severity of items as well as cluster analysis was used to reduce the number of total items to 22 (13 core, 9 brain tumor items). Regression analysis showed more than half (56%) of the variability in symptom severity was explained by brain module items. The MDASI-BT measures six underlying constructs including affective, cognitive, focal neurologic deficit, constitutional, generalized symptom, and a gastrointestinal related factor. The internal consistency (reliability) of the instrument was 0.91. The MDASI-BT was sensitive to disease severity based on performance status (PPP<0.001). Conclusions The 22 item MDASI-BT demonstrated validity and reliability in patients with PBT. This instrument can be used to identify symptom occurrence throughout the disease trajectory and to evaluate interventions designed for symptom management.This publication has 47 references indexed in Scilit:
- Variability of Momentary Pain Predicts Recall of Weekly Pain: A Consequence of the Peak (or Salience) Memory HeuristicPersonality and Social Psychology Bulletin, 2005
- A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, ItalyNeurological Sciences, 2005
- Content Validity of Self-Report Measurement Instruments: An Illustration From the Development of the Brain Tumor Module of the M.D. Anderson Symptom InventoryOncology Nursing Forum, 2005
- Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III TrialJournal of Clinical Oncology, 2004
- Prognostic value of quality of life scores in terminal cancer patientsJournal of Pain and Symptom Management, 1996
- Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancerJournal of Pain and Symptom Management, 1995
- Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening diseaseSocial Science & Medicine, 1983
- The Treatment of Glioblastoma Multiforme of the BrainJournal of Neurosurgery, 1967
- Glioblastoma Multiforme: A Clinical SurveyJournal of Neurosurgery, 1960
- Glioblastoma MultiformeJournal of Neurosurgery, 1958